Delivery Order SPE2DB24D1205-SPE2DB25FCRVM
Award Date
11/21/24
Potential Completion Date
12/13/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.18 firm fixed-price delivery order is for VYEPTI 100 MG/ML VIALML, with a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, including VYEPTI 100 MG/ML vials. The $4,270.04 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
The federal contract award is for the pharmaceutical product VYEPTI 100 MG/ML VIALML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on December 12, 2024, with a planned completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,405.06 firm fixed price delivery order is for VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,471.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 14, 2025 and was awarded on February 21, 2025. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.72, is a delivery order for the supply of VYEPTI 100 MG/ML VIALML, a medical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,141.00 issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of VYEPTI 100 MG/ML VIALML, a medical product, with a period of performance through October 11, 2023. This IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,943.08, is for the delivery of VYEPTI 100 MG/ML VIALML and has a completion date of May 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with the ID SPE2DB24D1205|SPE2DB25FCVMX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,943.08 Firm Fixed Price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 24, 2025 and does not have a set-aside designation, indicating open...